Suppr超能文献

基于解剖学因素的霍奇金病病理Ⅲ期预后分类

Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations.

作者信息

Desser R K, Golomb H M, Ultmann J E, Ferguson D J, Moran E M, Griem M L, Vardiman J, Miller B, Oetzel N, Sweet D, Lester E P, Kinzie J J, Blough R

出版信息

Blood. 1977 Jun;49(6):883-93.

PMID:861375
Abstract

Fifty-two patients with pathologic stage III Hodgkin disease were studied in an effort to determine whether location of involved abdominal nodes influenced survival. Treatment consisted of total nodal radiotherapy with or without subsequent combination chemotherapy. Th initial radiation field was the "extended mantle," which included supradiaphragmatic nodes, the splenic hilar area, and paraaortic nodes to the level of L2-L4. Subsequently, lower paraaortic and iliac regions were treated ("lower inverted Y"). Patients with disease limited to the spleen and/or splenic, celiac, or portal nodes ("anatomic substage" III1) had a more favorable 5-yr survival than did patients with involvement of paraaortic, iliac, or mesenteric nodes ("anatomic substage" III2): 93% versus 57%, respectively (p less than 0.05). The addition of combination chemotherapy to total nodal irradiation was associated with improved survival of patients in stage III2, but not of those in stage III1.

摘要

对52例病理分期为III期的霍奇金病患者进行了研究,以确定受累腹部淋巴结的位置是否影响生存。治疗包括全淋巴结放疗,可联合或不联合后续的联合化疗。初始放疗野为“扩大斗篷野”,包括膈上淋巴结、脾门区以及至L2-L4水平的腹主动脉旁淋巴结。随后,对腹主动脉下段和髂区进行治疗(“下倒Y野”)。病变局限于脾脏和/或脾、腹腔或门静脉淋巴结(“解剖亚分期”III1)的患者5年生存率比腹主动脉旁、髂或肠系膜淋巴结受累(“解剖亚分期”III2)的患者更有利:分别为93%和57%(p<0.05)。全淋巴结照射联合联合化疗可提高III2期患者的生存率,但对III1期患者无效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验